Carolina BioOncology (102) — Huntsville, North Carolina

Carolina BioOncology (102) is a clinical research site located in Huntsville, North Carolina, United States 28078.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Carolina BioOncology (102) has participated in 2 clinical trials.

Therapeutic areas: Solid Tumor, Adult.

Sponsors: Immune-Onc Therapeutics.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carolina BioOncology (102)?

Carolina BioOncology (102) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carolina BioOncology (102) conducted?

Carolina BioOncology (102) has 2 clinical trials on record. Their work covers Solid Tumor, Adult.

Is Carolina BioOncology (102) accredited by Crixeo Health?

Carolina BioOncology (102) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carolina BioOncology (102)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.